Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have earned an average rating of “Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have covered the stock in […]
Cellebrite DI Ltd. (NASDAQ:CLBTW – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 6,500 shares, a growth of 16.1% from the March 31st total of 5,600 shares. Based on an average daily trading volume, of 64,200 shares, the short-interest […]
Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price upped by Craig Hallum from $14.00 to $16.00 in a report released on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also recently commented on CLBT. Needham & Company LLC upped their target price on […]
Cellebrite DI (NASDAQ:CLBT – Get Free Report) had its price objective boosted by research analysts at Craig Hallum from $14.00 to $16.00 in a research note issued on Monday, Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price target indicates a potential upside of 45.19% from the stock’s previous […]
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) traded down 4.6% during trading on Wednesday . The stock traded as low as $11.29 and last traded at $11.32. 242,236 shares were traded during trading, a decline of 74% from the average session volume of 936,235 shares. The stock had previously closed at $11.87. […]